Journal article icon

Journal article

Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials.

Abstract:

BACKGROUND: Erythropoiesis-stimulating agents reduce anaemia in patients with cancer and could improve their quality of life, but these drugs might increase mortality. We therefore did a meta-analysis of randomised controlled trials in which these drugs plus red blood cell transfusions were compared with transfusion alone for prophylaxis or treatment of anaemia in patients with cancer. METHODS: Data for patients treated with epoetin alfa, epoetin beta, or darbepoetin alfa were obtained and a...

Expand abstract
Publication status:
Published

Actions


Access Document


Authors


Bohlius, J More by this author
Schmidlin, K More by this author
Brillant, C More by this author
Schwarzer, G More by this author
Expand authors...
Journal:
Lancet
Volume:
373
Issue:
9674
Pages:
1532-1542
Publication date:
2009-05-05
DOI:
EISSN:
1474-547X
ISSN:
0140-6736
URN:
uuid:68ebe3e2-2cb3-40a4-ac31-e6667a4cb4cd
Source identifiers:
79182
Local pid:
pubs:79182

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP